GlassScriptPhysician profile
Raghu Nandan
NPI 1861463606
$12,809.41
in general payments reported to CMS, 2019-2025
79 companies · $4,850 in 2025
The $4,850 reported for 2025 was more than what 82% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $194 · 2021: $181 · 2022: $323 · 2023: $3,603 · 2024: $3,309 · 2025: $4,850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Long Term Medical Supply Or Device Loan: $1,196 · Education: $16.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,548.99 |
| Long Term Medical Supply Or Device Loan | $1,196.40 |
| Education | $16.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,572.56 | 2023-2025 | |
| Pfizer INC. | $788.55 | 2022-2025 | |
| Incyte Corporation | $540.13 | 2022-2025 | Jakafi, Monjuvi, Pemazyre |
| Astrazeneca Pharmaceuticals LP | $525.68 | 2023-2025 | Enhertu, Tagrisso, Lynparza |
| Janssen Biotech, INC. | $511.05 | 2022-2025 | Tecvayli, Rybrevant, Darzalex |
| Merck Sharp & Dohme LLC | $475.13 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Daiichi Sankyo INC. | $407.12 | 2023-2025 | Enhertu, Datroway |
| Genzyme Corporation | $360.34 | 2022-2025 | |
| Celgene Corporation | $360.16 | 2023-2024 | Reblozyl, Pomalyst, Opdualag |
| Bayer Healthcare Pharmaceuticals INC. | $352.15 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $316.68 | 2024-2025 | Libtayo |
| Allergan, INC. | $304.73 | 2020-2021 | |
| Puma Biotechnology, INC. | $299.41 | 2023-2025 | |
| Genentech USA, INC. | $288.49 | 2021-2025 | Tecentriq, Phesgo, Perjeta |
| Karyopharm Therapeutics INC. | $265.10 | 2023-2025 | Xpovio |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Array Biopharma INC | $247.79 | 2023-2025 | Braftovi, Mektovi, Lorbrena |
| Alexion Pharmaceuticals, INC. | $245.04 | 2023-2025 | Ultomiris |
| Mentor Worldwide LLC | $238.13 | 2019-2022 | |
| Lilly USA, LLC | $225.95 | 2023-2025 | Jaypirca, Verzenio, Retevmo |
| Exelixis INC. | $211.38 | 2023-2025 | Cabometyx |
| E.R. Squibb & Sons, L.L.C. | $209.51 | 2022-2025 | Opdivo, Opdualag |
| Gilead Sciences, INC. | $200.64 | 2021-2025 | Trodelvy |
| Taiho Oncology, INC. | $184.03 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $183.67 | 2023-2024 | Fruzaqla, Alunbrig, Iclusig |
| Eisai INC. | $177.96 | 2023-2025 | |
| Stemline Therapeutics INC. | $165.68 | 2023-2025 | Orserdu |
| Janssen Scientific Affairs, LLC | $144.81 | 2023 | Erleada |
| Ipsen Biopharmaceuticals, INC | $131.64 | 2023-2024 | Onivyde, Somatuline Depot |
| Medical Device Business Services, INC. | $123.99 | 2019 | |
| Emd Serono, INC. | $122.41 | 2023-2025 | Bavencio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.50 | 2023-2025 | Gilotrif |
| Blueprint Medicines Corporation | $112.57 | 2023-2025 | Ayvakit |
| Sobi, INC | $109.32 | 2024-2025 | |
| Beigene USA, INC. | $108.56 | 2023-2025 | Brukinsa |
| Sanofi-Aventis U.S. LLC | $101.17 | 2023 | |
| Rigel Pharmaceuticals, INC. | $99.87 | 2023-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Cti Biopharma Corp. | $98.50 | 2023 | Vonjo |
| Progenics Pharmaceuticals, INC. | $95.35 | 2024-2025 | |
| Amgen INC. | $93.93 | 2023 | Kyprolis, Lumakras, Blincyto |
| Abbvie INC. | $88.95 | 2023-2024 | |
| Pharmacosmos Therapeutics INC. | $86.93 | 2023-2024 | Monoferric, Cosela |
| Jazz Pharmaceuticals INC. | $85.89 | 2023-2025 | Zepzelca |
| Sumitomo Pharma America, INC. | $81.65 | 2023-2025 | Orgovyx |
| Aveo Pharmaceuticals, INC. | $75.91 | 2024-2025 | |
| Genmab U.S., INC. | $62.83 | 2023 | Epkinly |
| Iovance Biotherapeutics, INC. | $61.08 | 2025 | Amtagvi |
| Agios Pharmaceuticals, INC. | $60.96 | 2023-2024 | Pyrukynd |
| Glaxosmithkline, LLC. | $60.93 | 2023-2025 | Ojjaara |
| Adaptive Biotechnologies Corporation | $60.81 | 2024-2025 | Clonoseq |
| Seagen INC. | $58.49 | 2023 | Padcev, Tukysa |
| Tempus Ai, INC | $53.48 | 2024-2025 | Xt Cdx |
| Morphosys, US INC. | $51.82 | 2023-2024 | Monjuvi |
| Mirati Therapeutics, INC. | $51.24 | 2023-2024 | Krazati |
| Astellas Pharma US INC | $51.14 | 2024-2025 | Xtandi |
| Apellis Pharmaceuticals, INC. | $45.97 | 2025 | Empaveli |
| Springworks Therapeutics, INC. | $43.90 | 2024-2025 | Ogsiveo |
| Azurity Pharmaceuticals, INC. | $42.13 | 2025 | Danziten |
| Beone Medicines USA, INC. | $34.86 | 2025 | Brukinsa |
| Caris Mpi, INC. | $34.46 | 2025 | Mi Cancer Seek |
| Immunocore Limited | $33.44 | 2024 | Kimmtrak |
| Geron Corporation | $32.90 | 2025 | Rytelo |
| Syndax Pharmaceuticals, INC. | $32.00 | 2025 | |
| Deciphera Pharmaceuticals INC. | $31.92 | 2023 | Qinlock |
| Foundation Medicine, INC. | $30.96 | 2023 | Foundationone Liquid Cdx |
| Sun Pharmaceutical Industries INC. | $30.59 | 2024 | |
| Shield Therapeutics INC | $30.47 | 2025 | |
| Cycle Pharmaceuticals INC | $30.00 | 2025 | Phyrago |
| Adc Therapeutics America, INC. | $28.33 | 2023 | |
| Novocure INC. | $27.52 | 2024 | Optune |
| Dendreon Pharmaceuticals LLC | $25.30 | 2025 | Provenge |
| Pharmaessentia USA Corporation | $24.66 | 2025 | Besremi |
| Legend Biotech USA INC. | $23.07 | 2025 | Carvykti |
| G1 Therapeutics, INC. | $21.05 | 2023 | Cosela |
| Immunogen, INC. | $20.41 | 2023 | Elahere |
| Chiesi USA, INC. | $17.50 | 2025 | Ferriprox |
| Servier Pharmaceuticals LLC | $16.41 | 2025 | |
| Catalyst Pharmaceuticals, INC. | $15.62 | 2023 | Firdapse |
| Integra Lifesciences Corporation | $13.60 | 2019 | |
| Spectrum Pharmaceuticals INC. | $13.55 | 2023 | Rolvedon |
Drugs and devices associated with these payments
Kisqali $1,371Enhertu $542Keytruda $448Sarclisa $346Libtayo $317Nubeqa $310Xtandi $287Orgovyx $276Xpovio $265Reblozyl $249Monjuvi $249Braftovi $248Ultomiris $245Erleada $244Tukysa $237Jaypirca $226Mektovi $224Jakafi $218Cabometyx $211Verzenio $202Tecentriq $194Inqovi $184Lonsurf $184Lenvima $178Pemazyre $172Ayvakit $166Orserdu $166Adcetris $153Ibrance $145Talzenna $145Brukinsa $143Nerlynx $141Pluvicto $141Tagrisso $139Padcev $138Elrexfio $134Onivyde $132Somatuline Depot $132Tecvayli $128Lorbrena $124Lynparza $124Opdivo $116Epkinly $114Imbruvica $111Rybrevant $111Darzalex $99.88Tavalisse $99.87Rezlidhia $99.87Opdualag $99.87Vonjo $98.50Pylarify $95.35Xalkori $94.08Welireg $92.12Bosulif $92.04Fruzaqla $89.88Zepzelca $85.89Pomalyst $80.61Fotivda $75.91Talvey $75.32Stivarga $73.43Vitrakvi $73.43Bavencio $72.11Gilotrif $68.63Retevmo $67.39Alunbrig $64.21Doptelet $64.05Kyprolis $62.37Cosela $61.76Amtagvi $61.08Clonoseq $60.81Besponsa $55.68Balversa $54.47Akeega $54.47Trodelvy $52.46Krazati $51.24Phesgo $49.24Oxbryta $48.20Ojjaara $47.38Inlyta $46.86Carvykti $46.71Monoferric $46.22Empaveli $45.97Synagis $45.27Ogsiveo $43.90Datroway $43.84Danziten $42.13Pyrukynd $40.08Elahere $37.21Wayrilz $37.05Gavreto $35.62Mi Cancer Seek $34.46Mekinist $34.15Kimmtrak $33.44Rytelo $32.90Qinlock $31.92Lumakras $31.56Foundationone Liquid Cdx $30.96Odomzo $30.59Yonsa $30.59Accrufer $30.47
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raghu Nandan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.